Scientists have established a mouse model for human malignant mesothelioma that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies. The research may eventually lead to a substantially improved outlook for patients with this devastating disease. Malignant mesothelioma is an aggressive cancer originating from the mesothelial lining of the pleural cavity and is associated with asbestos exposure and is characterized by a long latency period between exposure and disease onset.
